CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
基本信息
- 批准号:6691702
- 负责人:
- 金额:$ 33.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2005-12-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresisSalmonella infectionsbacteria infection mechanismbacterial antigensbacterial geneticsbactericidal immunitybiomarkercellular immunityenzyme linked immunosorbent assayflow cytometrygenetic mappinggenetic strainhelper T lymphocytelaboratory mousephagocytosisvesicle /vacuolevirulence
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Salmonella, Mycobacterium
and Histoplasma are facultative intracellular pathogens that live inside
phagosomes of host macrophages. They all cause AIDS-defining illnesses, and the
investigator's long-term goal is to understand the development of immunity
against such pathogens. CD4+ T cells are also required for immune mice to
resist virulent Salmonella, providing a model of protective host functions
which can successfully combat a macrophage-tropic infection. However, the
specific bacterial antigens (Ags) recognized by Salmonella-immune hosts are
largely unknown. Two proteins expressed in the surface-exposed "compartment" of
Salmonella are recognized by CD4+ T cells from immune mice. One is a flagellar
protein also recognized by T cells from humans immunized with Salmonella. The
other is an unidentified protein expressed by most Enterobacteriaceae,
including E. coli, Yersinia, Shigella, and Enterobacter. Both proteins are
regulated in a fashion suggesting part of the Salmonella intracellular survival
strategy is to down-regulate expression of bacterial surface Ags recognized by
CD4+ T cells. In AIM I, the diversity of Salmonella Ags recognized by CD4+ T
cells from immune mice will be determined using SDS-PAGE fractionated bacteria
as Ag, and bacterial expression of these Ags will be characterized with respect
to compartmentalization and regulation using T cell clones. The studies will
provide insight into the nature of Ags recognized by CD4+ T cells, the
environmental signals affecting bacterial processing Salmonella for T cell
responses. In AIM 2, genes encoding Ags recognized by T cell clones will be
identified by expression cloning or sequencing analysis of biochemically
purified Ags. This work may reveal gene products useful as markers of cellular
immunity to Salmonella in humans. In AIM 3, murine infection with Salmonella
strains expressing a model Ag in various compartments of the bacterial cell
will be used to directly test if compartmentalization of bacterial Ag alters
its significance for surveillance by T cells. Primary and secondary CD4+ T cell
responses generated by these stains will be quantified using ELISPOT and flow
cytometry, and the effectiveness of an Ag-specific immune response against
these strains will be tested in vivo. These studies will provide insight into
the nature of Ags recognized by CD4+ T cells responding to pathogens similarly
adapted for life in phagosomes. In AIM 4, the functional importance of Ags
identified in AIMS 1 & 2 will be determined by testing purified Ags for their
ability to stimulate protective immunity against challenge by virulent
Salmonella. The protective Ags identified will be excellent candidates for
components of subunit vaccines and markers of cellular immunity in humans.
描述(改编自申请人摘要):沙门氏菌、分枝杆菌
和组织胞浆菌是生活在
宿主巨噬细胞的吞噬体。它们都会导致艾滋病定义疾病,
研究者的长期目标是了解免疫力的发展
针对这些病原体。免疫小鼠也需要CD 4 + T细胞,
抵抗沙门氏菌,提供保护宿主功能的模型
其可以成功地对抗嗜巨噬细胞感染。但
沙门氏菌免疫宿主识别的特异性细菌抗原(Ag)是
大部分未知。两种蛋白质表达在表面暴露的“隔间”,
沙门氏菌被来自免疫小鼠的CD 4 + T细胞识别。一个是鞭毛
这种蛋白质也能被沙门氏菌免疫的人的T细胞识别。的
另一种是由大多数肠杆菌科表达的未鉴定的蛋白质,
包括大肠大肠杆菌、耶尔森氏菌、志贺氏菌和肠杆菌。这两种蛋白质都是
以一种暗示沙门氏菌细胞内存活的方式调节
策略是下调细菌表面抗原的表达,
CD 4 + T细胞。在AIM I中,CD 4 + T细胞识别的沙门氏菌抗原的多样性
将使用SDS-PAGE分级分离的细菌测定来自免疫小鼠的细胞
作为Ag,这些Ag的细菌表达将在以下方面进行表征:
到使用T细胞克隆进行区室化和调节。这些研究将
提供了深入了解由CD 4 + T细胞识别的Ag的性质,
环境信号影响沙门氏菌对T细胞的加工
应答在AIM 2中,编码被T细胞克隆识别的Ags的基因将被克隆。
通过表达克隆或生物化学的测序分析鉴定
纯化的Ags。这项工作可能揭示基因产物作为细胞标志物的有用
人类对沙门氏菌的免疫力在AIM 3中,鼠感染沙门氏菌
在细菌细胞的各个区室中表达模型Ag的菌株
将用于直接测试细菌Ag的区室化是否改变
它对T细胞监视的重要性。原代和次级CD 4 + T细胞
将使用ELISPOT和流式细胞仪定量这些染色剂产生的反应。
流式细胞术,以及Ag特异性免疫应答对
这些菌株将在体内进行测试。这些研究将提供深入了解
CD 4 + T细胞识别的抗原对病原体的反应类似于
适应了吞噬体的生活在AIM 4中,Ags的功能重要性
AIMS 1和2中鉴定的AGS将通过测试纯化的AGS的
刺激保护性免疫力对抗强毒攻击的能力
沙门氏菌。所确定的保护性AG将是优秀的候选人,
亚单位疫苗的组分和人类细胞免疫的标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRAD T COOKSON其他文献
BRAD T COOKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRAD T COOKSON', 18)}}的其他基金
Caliper Life Sciences IVIS Lumina II imaging system
Caliper 生命科学 IVIS Lumina II 成像系统
- 批准号:
8246848 - 财政年份:2012
- 资助金额:
$ 33.81万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
8236985 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别:
Immune Correlates and Mechanisms of Controlling NTS Bacteremia
免疫相关性和控制 NTS 菌血症的机制
- 批准号:
8026709 - 财政年份:2010
- 资助金额:
$ 33.81万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
7675881 - 财政年份:2009
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6285611 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6488760 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6836493 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6626383 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
相似海外基金
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
定义血清型交叉反应的免疫学机制,以开发针对人类伤寒和非伤寒沙门氏菌感染的广谱保护性疫苗
- 批准号:
10584484 - 财政年份:2019
- 资助金额:
$ 33.81万 - 项目类别:
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
定义血清型交叉反应的免疫学机制,以开发针对人类伤寒和非伤寒沙门氏菌感染的广谱保护性疫苗
- 批准号:
10364714 - 财政年份:2019
- 资助金额:
$ 33.81万 - 项目类别:
Optimising temporal genomic surveillance of Salmonella infections in Australia
优化澳大利亚沙门氏菌感染的时间基因组监测
- 批准号:
nhmrc : GNT1129713 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Project Grants
Optimising temporal genomic surveillance of Salmonella infections in Australia
优化澳大利亚沙门氏菌感染的时间基因组监测
- 批准号:
nhmrc : 1129713 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Project Grants
Host and bacterial factors driving chronic Salmonella infections (A08)
驱动慢性沙门氏菌感染的宿主和细菌因素 (A08)
- 批准号:
317067475 - 财政年份:2016
- 资助金额:
$ 33.81万 - 项目类别:
Collaborative Research Centres
Evaluation of the human burden of disease from third generation cephalosporin resistant Escherichia coli and Salmonella infections and the contribution from antimicrobial use in food producing animals
评估第三代头孢菌素耐药性大肠杆菌和沙门氏菌感染造成的人类疾病负担以及食用动物中抗菌药物使用的贡献
- 批准号:
365485 - 财政年份:2016
- 资助金额:
$ 33.81万 - 项目类别:
Studentship Programs
Molecular Mechanisms of Inflammasome Activation During Salmonella Infections
沙门氏菌感染期间炎症小体激活的分子机制
- 批准号:
8966608 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别:
Molecular Mechanisms of Inflammasome Activation During Salmonella Infections
沙门氏菌感染期间炎症小体激活的分子机制
- 批准号:
8770016 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别:
Molecular Mechanisms of Inflammasome Activation During Salmonella Infections
沙门氏菌感染期间炎症小体激活的分子机制
- 批准号:
8386949 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别:
Molecular Mechanisms of Inflammasome Activation During Salmonella Infections
沙门氏菌感染期间炎症小体激活的分子机制
- 批准号:
8243485 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别: